Creutzfeldt-Jakob disease

Common Name(s)

Creutzfeldt-Jakob disease, CJD

Creutzfeldt-Jakob disease (CJD) is a type of rapidly progressive brain disorder known as prion disease. Prion disease is very rare and affects about one in every one million people per year. Symptoms of CJD typically develop around age 60 and can include trouble with memory along with changes in behavior, vision, and coordination. As the disease progresses, the severity of the symptoms increase.

The three variations of CJD are labeled as sporadic, hereditary, and acquired. Researchers believe the sporadic variation, which is most common, could be due to an incorrectly folded protein in the body, called an infectious prion. The prions clump together and cause damage to the brain, leading to the symptoms of CJD. The hereditary variation, which occurs much less often, is also caused by clumped prions. However, in the hereditary version, the abnormally folded prions are caused by a change (mutation) in the PRNP gene. The acquired variation of CJD is the least common and can occur when an individual comes in contact with the brain tissue or spinal fluid of an affective organism, such as eating the brain tissue of an affected cow (also known as mad cow disease). This variation accounts for about 1% of CJD cases.

Because CJD has symptoms similar to other forms of dementia, a doctor may attempt to rule out other conditions before suggesting a diagnosis of CJD. A medical professional may also perform a brain scan, such as an MRI, to look for changes in the brain tissue that are characteristic of CJD. The current treatments available for CJD focus on minimizing the symptoms associated with the disease. Researchers are trying to better understand what causes CJD in order to develop more effective treatments. If you or a family member has been diagnosed with CJD, talk with your doctor and specialists about the most current treatment options. Support groups are a good resource for additional information and support.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Creutzfeldt-Jakob disease" for support, advocacy or research.

Logo
The CJD Foundation

The Creutzfeldt-Jakob Disease Foundation consists of members who are concerned about the complexity of issues surrounding this fatal brain disease. Our mission is to support families and loved ones touched by CJD.

Last Updated: 11 Mar 2013

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Creutzfeldt-Jakob disease" for support, advocacy or research.

Logo
The CJD Foundation

The Creutzfeldt-Jakob Disease Foundation consists of members who are concerned about the complexity of issues surrounding this fatal brain disease. Our mission is to support families and loved ones touched by CJD.

http://www.cjdfoundation.org

Last Updated: 11 Mar 2013

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Creutzfeldt-Jakob disease" returned 508 free, full-text research articles on human participants. First 3 results:

A test for Creutzfeldt-Jakob disease using nasal brushings.
 

Author(s): Gianluigi Zanusso, Matilde Bongianni, Byron Caughey

Journal: N. Engl. J. Med.. 2014 Nov;371(19):1842-3.

 

Last Updated: 6 Nov 2014

Go To URL
White matter involvement in sporadic Creutzfeldt-Jakob disease.
 

Author(s): Eduardo Caverzasi, Maria Luisa Mandelli, Stephen J DeArmond, Christopher P Hess, Paolo Vitali, Nico Papinutto, Abby Oehler, Bruce L Miller, Irina V Lobach, Stefano Bastianello, Michael D Geschwind, Roland G Henry

Journal: Brain. 2014 Dec;137(Pt 12):3339-54.

 

Sporadic Creutzfeldt-Jakob disease is considered primarily a disease of grey matter, although the extent of white matter involvement has not been well described. We used diffusion tensor imaging to study the white matter in sporadic Creutzfeldt-Jakob disease compared to healthy control ...

Last Updated: 21 Nov 2014

Go To URL
The prion protein protease sensitivity, stability and seeding activity in variably protease sensitive prionopathy brain tissue suggests molecular overlaps with sporadic Creutzfeldt-Jakob disease.
 

Author(s): Alexander H Peden, Deep P Sarode, Carl R Mulholland, Marcelo A Barria, Diane L Ritchie, James W Ironside, Mark W Head

Journal:

 

Variably protease sensitive prionopathy (VPSPr) is a recently described, sporadic human prion disease that is pathologically and biochemically distinct from the currently recognised sporadic Creutzfeldt-Jakob disease (sCJD) subtypes. The defining biochemical features of the abnormal ...

Last Updated: 31 Oct 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Creutzfeldt-Jakob disease" returned 45 free, full-text review articles on human participants. First 3 results:

Distinct origins of dura mater graft-associated Creutzfeldt-Jakob disease: past and future problems.
 

Author(s): Atsushi Kobayashi, Yuichi Matsuura, Shirou Mohri, Tetsuyuki Kitamoto

Journal:

 

Dura mater graft-associated Creutzfeldt-Jakob disease (dCJD) can be divided into two subgroups that exhibit distinct clinical and neuropathological features, with the majority represented by a non-plaque-type of dCJD (np-dCJD) and the minority by a plaque-type of dCJD (p-dCJD). The ...

Last Updated: 8 Apr 2014

Go To URL
Interpretation of cerebrospinal fluid protein tests in the diagnosis of sporadic Creutzfeldt-Jakob disease: an evidence-based approach.
 

Author(s): Michael B Coulthart, Gerard H Jansen, Neil R Cashman

Journal: CMAJ. 2014 Jun;186(9):E333-9.

 

Last Updated: 10 Jun 2014

Go To URL
Management of notifications of donors with Creutzfeldt-Jakob disease (post-donation information).
 

Author(s): Gabriele Calizzani, Stefania Vaglio, Vito Vetrugno, Marisa Delbò, Luca Pani, Giuliano Grazzini

Journal: Blood Transfus. 2014 Jan;12(1):22-7.

 

Last Updated: 19 Feb 2014

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Notification of Donors With Positive Microbiology Markers
 

Status: Not yet recruiting

Condition Summary: Human Immunodeficiency Virus; Hepatitis B; Hepatitis C; Human T-lymphotropic Virus I & II; Creutzfeldt-Jakob Syndrome; HIV Infections

 

Last Updated: 12 Feb 2010

Go to URL
The Role of the Coagulation Pathway at the Synapse in Prion Diseases
 

Status: Not yet recruiting

Condition Summary: Creutzfeldt-Jakob Syndrome

 

Last Updated: 23 Jun 2015

Go to URL